CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BMRN: Lowering target price to $67.00

Negative
AI Analysis

Summary

An analyst lowered Biomarin Pharmaceutical's price target to $67.00, suggesting a negative outlook on the stock's near-term valuation.

Importance:2/10
Sentiment:
-0.60
price_targetvaluation
Related Companies

Read the original article

Published by yahoo_finance on August 5, 2026 12:00 AM

Read Original